Related Experiment Video
Updated: Oct 19, 2025

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
Brain Microvascular Endothelial Cell-Derived HMGB1 Facilitates Monocyte Adhesion and Transmigration to Promote JEV
Song-Song Zou1,2,3,4, Qing-Cui Zou1,2,3,4, Wen-Jing Xiong1,2,3,4
1State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
Abstract:
Infection with Japanese encephalitis virus (JEV) induces high morbidity and mortality, including potentially permanent neurological sequelae. However, the mechanisms by which viruses cross the blood-brain barrier (BBB) and invade into the central nervous system (CNS) remain unclear. Here, we show that extracellular HMGB1 facilitates immune cell transmigration. Furthermore, the migration of immune cells into the CNS dramatically increases during JEV infection which may enhance viral clearance, but paradoxically expedite the onset of Japanese encephalitis (JE). In this study, brain microvascular endothelial cells (BMECs) were utilized for the detection of HMGB1 release, and leucocyte, adhesion, and the integrity of the BBB in vitro. Genetically modified JEV-expressing EGFP (EGFP-JEV) and the BBB model were established to trace JEV-infected immune cell transmigration, which mimics the process of viral neuroinfection. We find that JEV causes HMGB1 release from BMECs while increasing adhesion molecules. Recombinant HMGB1 enhances leukocyte-endothelium adhesion, facilitating JEV-infected monocyte transmigration across endothelia. Thus, JEV successfully utilizes infected monocytes to spread into the brain, expanding inside of the brain, and leading to the acceleration of JE onset, which was facilitated by HMGB1. HMGB1-promoted monocyte transmigration may represent the mechanism of JEV neuroinvasion, revealing potential therapeutic targets.
Insights
Japanese encephalitis virus (JEV) invades the brain by hijacking immune cells, a process accelerated by HMGB1. This discovery reveals HMGB1 as a potential therapeutic target for preventing JEV neuroinvasion and Japanese encephalitis.
Area of Science:
- Neurovirology
- Immunology
- Cell Biology
Background:
- Japanese encephalitis virus (JEV) infection causes severe neurological damage and mortality.
- The precise mechanisms of JEV entry into the central nervous system (CNS) across the blood-brain barrier (BBB) are not fully understood.
Purpose of the Study:
- To elucidate the role of High-Mobility Group Box 1 (HMGB1) in JEV neuroinvasion.
- To investigate how JEV-infected immune cells cross the BBB.
Main Methods:
- Utilized brain microvascular endothelial cells (BMECs) to study HMGB1 release, leukocyte adhesion, and BBB integrity in vitro.
- Established a BBB model with genetically modified EGFP-JEV to track infected immune cell transmigration.
Main Results:
- JEV infection induces HMGB1 release from BMECs and upregulates adhesion molecules.
- Recombinant HMGB1 enhances leukocyte-endothelium adhesion and facilitates JEV-infected monocyte transmigration.
- JEV utilizes infected monocytes to enter the brain, accelerating Japanese encephalitis (JE) onset.
Conclusions:
- HMGB1 facilitates JEV-infected monocyte transmigration across the BBB, representing a key mechanism for JEV neuroinvasion.
- Targeting HMGB1-mediated monocyte migration offers a potential therapeutic strategy against JEV-induced neuroinflammation and encephalitis.
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cancer Cell Migration through Invadopodia
Cell Migration
The Blood-brain Barrier
Intracellular Signaling Affects Focal Adhesions
Some...

